Cargando…

Mono or Dual Antiplatelet Therapy for Treating Patients with Peripheral Artery Disease after Lower Extremity Revascularization: A Systematic Review and Meta-Analysis

The efficacy of dual antiplatelet therapy (DAPT) for patients with peripheral artery disease (PAD) after lower-limb intervention remains controversial. Currently, the prescription of DAPT after an intervention is not fully recommended in guidelines due to limited evidence. This study compares and an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Shang-Yu, Li, Ying-Sheng, Lee, Che-Hsiung, Cha, Shion-Wei, Wang, Yao-Chang, Su, Ta-Wei, Yu, Sheng-Yueh, Yeh, Chi-Hsiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144146/ https://www.ncbi.nlm.nih.gov/pubmed/35631422 http://dx.doi.org/10.3390/ph15050596

Ejemplares similares

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

Dual versus mono antiplatelet therapy in mild‐to‐moderate stroke during hospitalization
por: Fan, Haimei, et al.
Publicado: (2022)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms
por: Meyer, Benjamen M., et al.
Publicado: (2023)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
por: Zhang, Shuqi, et al.
Publicado: (2022)

Very Short Versus Longer Dual Antiplatelet Treatment After Coronary Interventions: A Systematic Review and Meta-analysis
por: Tsigkas, Grigorios, et al.
Publicado: (2022)

Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
por: Geng, Xue, et al.
Publicado: (2020)

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis
por: Xie, Wuxiang, et al.
Publicado: (2015)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

Artificial-Intelligence-Assisted Discovery of Genetic Factors for Precision Medicine of Antiplatelet Therapy in Diabetic Peripheral Artery Disease
por: Yeh, Chi-Hsiao, et al.
Publicado: (2022)

Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review
por: Confalonieri, Filippo, et al.
Publicado: (2023)

Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
por: Feng, Wen-Han, et al.
Publicado: (2022)

Myocardial revascularization at extremes – surgical revascularization in acute coronary syndrome
por: Kacar, S, et al.
Publicado: (2013)

Dual-gated mono–bilayer graphene junctions
por: Du, Mingde, et al.
Publicado: (2020)

Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis
por: Tsigkas, Grigorios, et al.
Publicado: (2023)

Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy
por: Huang, Sheng-Wei, et al.
Publicado: (2022)

Does Surgical Repair Benefit Pipkin Type I Femoral Head Fractures?: A Systematic Review and Meta-Analysis
por: Tsai, Sung Huang Laurent, et al.
Publicado: (2022)

Should Antiplatelet Therapy Be Held Perioperatively? The First Study Examining Outcomes in Patients Receiving Dual Antiplatelet Therapy in the Lower Extremity Free Flap Population
por: Bekeny, Jenna C., et al.
Publicado: (2020)

Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
por: Yang, Yingying, et al.
Publicado: (2018)

Efficacy and Safety of Short-Term Dual Antiplatelet Therapy in East Asians: A Systematic Review and a Meta-Analysis of Randomized Clinical Trials
por: Ma, Ying, et al.
Publicado: (2022)

Antiplatelet Therapy for Acute Respiratory Distress Syndrome
por: Chen, Chuan-Mu, et al.
Publicado: (2020)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction – A 13-year nationwide cohort study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2019)

Trial Sequential Analysis and Updated Meta-Analysis of Fluvoxamine on Clinical Deterioration in Adult Patients with Symptomatic COVID-19 Infection
por: Yu, Chia-Ling, et al.
Publicado: (2023)

Time to Prescribe Dual instead of Mono
por: Choi, Joon Young
Publicado: (2021)

Is Revascularization the Treatment of Choice for Traumatized Necrotic Immature Teeth? A Systematic Review and Meta-Analysis
por: Swaikat, Mohamad, et al.
Publicado: (2023)

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
por: Chen, Shih-Chin, et al.
Publicado: (2014)

Antiplatelets Versus Anticoagulation in Cervical Artery Dissection: A Systematic Review and Meta-analysis of 2064 Patients
por: Hagrass, Abdulrahman Ibrahim, et al.
Publicado: (2022)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐Analysis
por: Brouwer, Jorn, et al.
Publicado: (2021)

Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
por: Albay, Christessa Emille Que, et al.
Publicado: (2020)

Optimal Perioperative Nutrition Therapy for Patients Undergoing Pancreaticoduodenectomy: A Systematic Review with a Component Network Meta-Analysis
por: Wang, Shang-Yu, et al.
Publicado: (2021)

Antiplatelet therapy and incident cognitive impairment or dementia—a systematic review and meta-analysis of randomised clinical trials
por: Kitt, Kevin, et al.
Publicado: (2023)

Dual Antiplatelet Therapy in Coronary Artery Disease
por: Sharma, Raghav, et al.
Publicado: (2020)

Is Paclitaxel Causing Mortality During Lower‐Extremity Revascularization?
por: Swaminathan, Rajesh V., et al.
Publicado: (2019)

Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
por: Liga, Riccardo, et al.
Publicado: (2023)

Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
por: Huseynov, Aydin, et al.
Publicado: (2019)

The effects of secondary prevention after coronary revascularization in Taiwan
por: Feng, Wen-Han, et al.
Publicado: (2019)

P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis
por: Feng, Wen-Han, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9v8jbducbngc82gd6dje1d4rj8